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Abstract
Background: Accurate estimation of antimicrobial use (AMU) is important
in assessing reduction of agricultural AMU. This cross-sectional study aimed
to evaluate several approaches for estimating AMU at the herd level and to
report on AMU for beef and dairy farms in Scotland.
Methods: Pharmaceutical sales data for 75 cattle herds (2011–2015) were
screened for antimicrobial products and aggregated by herd and year. Several
denominators for usage estimates were calculated and compared for their
suitability at the herd level.
Results: The median total mass of active ingredient sold per kg of bovine live-
stock was 9.5 mg/kg for beef herds and 14.3 mg/kg for dairy herds. The ‘high-
est priority critically important’ antimicrobials (HPCIA) were by total mass
of active ingredient, 10.6% of all sales; by total defined daily dose veterinary
(DDDVet), 29.8% and by DCDvet, 20.0%. These are the first estimates of AMU
for beef cattle in the UK, and for cattle of any kind in Scotland.
Estimates of herd-level usage based on population correction unit (PCU) were
sensitive to low values for PCU for specific herd-years due to their demo-
graphic composition.
Conclusion: Pharmaceutical sales data can provide useful estimates of AMU,
but estimating usage per PCU is not appropriate for comparing groups of cat-
tle with different demographic compositions or for setting herd-level targets.
Total mass of active ingredient per kilogram of livestock is more stable and
hence suitable than PCU-based methods for assessing AMU at the herd level.
INTRODUCTION
Antimicrobial resistance is a concern to animal and
human health due to the risk of antimicrobial treat-
ment failure.1,2 Of primary concern is treatment fail-
ure in humans3 and hence concern of possible transfer
of resistance between animals and humans. Strategies
for mitigating antimicrobial resistance in humans and
animals have been recommended,2 including defining
country-level targets to reduce the use of antibiotics
in agriculture. The UK government pledged to “reduce
antibiotic use in livestock and fish farmed for food to a
multispecies average of 50 mg/kg by 2018″.4
In 2017, the Targets Task Force of the Responsible
Use of Medicines in Agriculture Alliance (RUMA) set a
target for the UK beef sector of either a 10% reduction
on the 2016 figures, or of 10 mg/population correction
unit (PCU) – whichever is lower on a mg/PCU basis.5
For the UK dairy sector, the RUMA target for the total
antimicrobial usage (AMU) is 21.0 mg/PCU by 2020.5
The “population correction unit” is defined within
Veterinary Medicines Directorate guidance as ‘the
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standardised average mass in of all animals at time of
treatment multiplied by the number of animals based
on national statistics (live and/or slaughter);.6 These
PCU calculations were standardised and are typically
used, for purposes of national level statistics, the most
recent of which suggest a general downward trend for
the UK, with headline figures of 17 mg/kg in dairy and
21 mg/kg in beef.7
We require good estimates of AMU to inform tar-
get setting and to assess progress towards those tar-
gets. Ideally, national targets would be translated
into herd-level targets to facilitate both high-level
national/strategic decisions and lower herd-level deci-
sions. Targets need to be appropriate for the level at
which they are applied, and different target types may
be needed for different levels. Three relevant and com-
mon measures of AMU are the following:
∙ The total mass of active ingredient (a.i.) of antimi-
crobials administered per kg of animal,8
∙ The ‘defined daily dose veterinary’ (DDDvet):
assumed average dose (i.e., total mass in mg of a.i.)
per kg animal per day of treatment,9
∙ The “Defined Course Dose Veterinary” (DCDvet):
assumed average dose (total mass of a.i.) per kg ani-
mal per treatment course.9
Estimates of AMU have been made for English dairy
herds,10 but, to our knowledge, there are no published
estimates for beef cattle anywhere in the UK or for cat-
tle of any kind in Scotland. Beef production in Scot-
land is dominated by a particularly extensive form of
production.
Our aims were to evaluate several approaches for
the measurement of AMU for their suitability at the
herd level and to provide initial estimates of AMU at
the herd level for Scottish cattle based on antimicro-




The participating veterinary practice identified all
commercial cattle farms (defined as those having
more than 20 breeding cows) on its client list. Two
farms were excluded because they were owned by
members of the veterinary practice and thus con-
sidered atypical. The study size was determined by
the available data. Pharmaceutical sales data were
extracted from the practice database for each of these
farms for each year between 2011 and 2015, inclu-
sive. Farms were identified at the veterinary practice
by County-Parish-Holding (CPH) number.
The numbers of beef and dairy cattle of differ-
ent age classes (see the Supporting Information) on
each of these farms at the time of the annual Agri-
cultural and Horticultural Census in June of each
year was extracted from data provided by the Scottish
Government’s Rural and Environment Science and
Analytical Services Division (RESAS), with its per-
mission. In order to maintain the anonymity of the
farms, personnel in the participating vet practice office
executed software that (1) extracted relevant demo-
graphic information from census data, (2) matched
demographic data to pharmaceutical sales data based
on the CPH number and (3) replaced the CPH num-
ber with an anonymized number. All potentially iden-
tifying information was withheld from researchers
involved in the analysis.
Data cleaning
Demographic data
Herds were categorised as dairy or beef based on the
veterinarian’s knowledge of whether the herd was pro-
ducing dairy products during the 2011–2015 period.
We chose not to include a category ‘mixed’ to keep
the comparisons simple. This is consistent with the
Scottish Dairy Cattle Association’s definition of a dairy
herd: a ‘farm that produces milk, from cows, for retail
to a milk buyer for payment’.11 We did not account for
sheep, on the basis that where AMU for sheep has been
measured, the estimates have been low in comparison
to other livestock species.12,13
Pharmaceutical sales data
Any product containing a substance acting as an
antibacterial agent (excluding disinfectants, anti-
fungals and anthelmintics) was deemed to be an
‘antimicrobial’. These products are listed in Table S3
(Supporting Information).
Antimicrobial sales records were retrieved via
a sequence of filters illustrated in Figure Supp1
(Supporting Information). Records relating solely to
species other than cattle or to non-antimicrobial prod-
ucts were discarded. Products with more than one tar-
get species including cattle were retained.
Defining the relevant characteristics of each
product sold
Characteristics of each antimicrobial product were
obtained and documented (see the Supporting Infor-
mation). Unit prices were based on the practice’s own
data which pertained to the relevant time period.
Data processing
The quantity of antimicrobial active ingredient within
each sale was estimated by dividing the price of that
sale by the unit product price and multiplying by the
quantity of that antimicrobial in the unit product.
Quantities were aggregated as follows:
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∙ Total mass of antimicrobial active ingredient (a.i.)
used [excluding topical aerosols]
∙ DDDvet,9 [excluding dry-cow intramammaries, top-
icals – both aerosol and non-aerosol]
∙ DCDvet,9 [excluding topicals – both aerosol and
non-aerosol]
Data analysis
Mass (mg) a.i. per denominator unit
For each herd-year, the total mass of antimicrobial
a.i. per kg of animal – a ‘’primary indicator’14 – was
estimated based on the standard masses of animals
described by the PCU.6 Other denominators were also
assessed, as described below and within the Support-
ing information: Table S1 and equations. All routes
of antimicrobial administration were included for the
calculation of total mass of a.i. per PCU except aerosol
sprays.10,15
DDDvet and DCDvet
DDDvet units and DCDvet units are defined by EMA.9
The ratio metrics (usage per measure of herd size) are
calculated differently depending upon the administra-
tion route (Table S2 and equations in the Supporting
Information)
Parenteral and oral antimicrobials
For parenteral and oral antimicrobials, we calculated
the number of DDDvet and DCDvet per kg of adult
cow by dividing the total DDDvets and DCDvets for
each antimicrobial9 in the packet(s) sold by the stan-
dard number of kg of all the adult cows (425 kg per
cow)16 in the herd. As the standardised mass of adult
cows is unlikely to be appropriate (or even defined) for
beef herds, we also used as our denominator the total
mass of all cattle based on the standard set of masses16
for both dairy and beef herds.
Intramammary antimicrobials
The DDDvet unit is defined by the unit dose of one
dose per teat (commonly known as a ‘tube’), and the
DCDvet is the unit dose for one course for one teat
(typically three ‘tubes’).15 The standard denominator
for both DDDvet and DCDvet for intra-mammaries is
the number of adult cows. Note that for dry lactating
cow intramammary therapy, there is no definition of
DDDvet which is therefore not reported.8,9
Intrauterine antimicrobials
The DDDvet and DCDvet for intrauterine antimicro-
bials are defined as units of ‘IUP’ or intrauterine prod-
uct (pessary or tube). We then divided this by the total
number of adult cows in the herd for that year to
get the number of DDDvets and DCDvets per adult
cow.
For the calculation percentage of the total DDDvet
or DCDvet that was ‘highest priority critically impor-
tant’ antimicrobials (HPCIA), we summed the relevant
numerator and divided by the summed denomina-
tor across all categories of records which shared the
same definition of numerator and denominator to get
the standard DDDvet or DCDvet. We then summed
this calculated DDDvet or DCDvet from each of those
two categories together. This was done for records that
were HPCIA and compared to all records irrespective
of their HPCIA status.
Topical/aerosol antimicrobials
Similarly topical products and aerosol spray products
were not included in either DDDvet or DCDvet (dose
undefined).
Denominator for beef and dairy herds
We used several approaches for calculating the PCU
or other denominator mass: two for beef and three
for dairy herds (Tables S1 and S2 and accompanying
equations in the Supporting information), to facilitate
comparison at the herd level and between these two
sectors.
The EMA propose that the PCU for beef produc-
tion be based on the number of animals going to
slaughter.16,17 In our case, this approach for calculat-
ing a PCU for beef herds was not directly applicable:
we had data for animals present, rather than for those
going to slaughter. Consequently for beef farms, we
chose to use the following denominators:
∙ DenB_slaught: the sum of the PCU masses (see
Table 3 of Appendix 2 in EMA, 2011,16) for cattle of
both genders and both dairy/beef classifications in
the age group 1–2 years, together with male cattle
over the age of 2, which should approximately rep-
resent the mass of animals going to slaughter. This
is the standard proposed by EMA.16
∙ Den_cows: To allow for the presence of beef ani-
mals on dairy farms (see below), we calculated the
PCU for each herd-year in beef herds based on
all cows over 2 years old of both dairy and beef
breeds.
∙ Den_all: the sum of PCU masses of all bovines
present in beef herds based on the standard PCU
masses for each age class.16
For dairy herds, we used the following denomina-
tors:
∙ PCUD_std: The standard proposed by EMA16 is the
total PCU for dairy herds is based on the standard
PCU for a ‘livestock’ dairy cow (425 kg)16 multi-
plied by the number of dairy cows (with or without
calves).
∙ Den_cows: To account for the presence of beef ani-
mals on dairy farms, we calculated the alterna-
tive total PCU (described above for beef herds)
for each dairy herd-year, which was based on all
cows over two years old of both dairy and beef
breeds.
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T A B L E 1 Size profile of the herds in our study compared with that of Scottish herds as derived from the Scottish Government (tables
C11, C12 (The Scottish Government 2017))

















1–4 38.9 12.8 1–4 20.7 8.4
5–19 6.4 2.0 5–19 24.1 18.6
20–49 4.1 5.9 20–49 22.3 33.5
50–74 5.9 25.1 50–74 11.3 16.0
75–99 6.7 25.1 75–99 7.7 8.4
100–149 13.9 12.8 100–149 7.8 10.3
150 &and over 24.1 16.3 150 and over 6.1 4.9
aFemale dairy cattle aged 2 years or over with offspring.
bFemale beef cattle aged 2 years or over with offspring.
∙ Den_all: Finally, to facilitate comparison with results
from beef herds, we used the same denominator
for dairy herds, which was the total mass (kg) of all
bovine animals recorded on the farm for each herd-
year and based on the standard PCU masses for each
age class.16
In all calculations, any observation (herd-year) for
which no animals were recorded at the time of the June
census was removed from the calculation of the sum-
mary statistics. A single herd with no recorded animals
in four out of five herd years as also removed from
this calculation. Any herd-year for which there were
no pharmaceutical sales at all was treated as missing
rather than zero.
Data processing and analysis was carried out in R
version 3.4.418 using core R plus packages dplyr and
ggplot2, and Microsoft Excel.
Ethical approval
Following the submission of an SRUC ethical approval
application form (02/04/2019), we were advised that
due to the nature of the study no further ethical
approval was required.
RESULTS
Pharmaceutical sales and herd demographic data were
obtained for the years 2011–2015 for 39 beef and 36
dairy herds. There were several examples of dairy cat-
tle in beef herds (33 out of the 193 beef herd-years) and
of beef cattle in dairy herds (159 out of the 180 dairy
herd-years).
Herd size
Compared to the range of herd sizes found in Scotland,
in our study we had fewer large and small dairy herds.
For beef herds we had fewer small herds but otherwise
had a similar size distribution to Scotland as a whole
(Table 1).
Consumption patterns of antimicrobials
In aggregate, the total consumption of antimicrobial
among beef herds was 9.5 mg/kg of bovine animal and
14.3 mg/kg for dairy herds.
Mass (mg) a.i. per kg or PCU for beef and
dairy herds
Patterns for mass of a.i. used per kg or PCU are shown
in Table 2. In most cases, the mean was substantially
higher than the median amount of a.i. used, indicating
wide ranges and high maximums of AMU across herd-
years for each of the different measures. The highest
values of mass of antimicrobial per denominator
came from herd-years with the lowest denominator
values.
DDDvet and DCDvet
Due to the uncertainty in the denominator for the
DDDvet and DCDvet, results are separated according
to the calculation adopted, following the ESVAC/EMA
guidelines (Table 3). Dairy herds used more DDDvet
and DCDvet than beef herds in each of the respective
comparisons where the same denominator is applied
(Table 3). Usage was slightly higher (per kg of all
animals) in dairy than in beef herds in the case of
oral and parenteral administered products, and sev-
eral times higher (per adult cow) in the case of intra-
mammary and intrauterine products. The DDDvet
was, in general, about three times higher than the
DCDvet.
Administration route
For all routes of administration, dairy herds were sold
more total antimicrobials (by mass, DDDvet or DCD-
vet per kg of bovines) than beef herds in this study
(Figure 1(a)–(c)). As expected, both proportionately
and absolutely, beef herds received very low quantities
of antimicrobial via the intramammary route.
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T A B L E 2 Weight of active ingredient (mg of antimicrobial) per PCU or per kg, p.a. per herd or aggregated over all herd-years (and routes
of administration) to give the total weight of active ingredient divided by the total PCU or kg of animal
Beef PCU based on
all animals 1–2
years old and males
over 2 years
old(DenB_slaught)a
BeefAll cows over 2


















Mean 267.4 17.8 12.3 30.4 25.0 16.2
Median 76.5 14.0 9.48 23.8 19.8 13.7




81.9 15.04 10.1 24.8 22.4 15.3
aDenotes the official EMA standard PCU. Herd years in which the denominator was zero have been excluded in the calculations.
Route of administration and antimicrobial
class
Figure 2 presents the total mass of antimicrobials (per
kg of all bovines) sold by herd type, antimicrobial
class and route of administration. For all classes and
routes, more antimicrobial was sold to dairy herds
than to beef herds. The dominant route of adminis-
tration was parenteral, and the two most dominant
classes of antimicrobials were beta lactam (excluding
third-/fourth-generation cephalosporins) and amino-
glycoside.
Highest priority critically important
antimicrobials
By mass, 10.6% (1.42 mg/kg of bovine animals) of
the total antimicrobial sold was classified as highest
priority critically important antimicrobial for human
medicine HPCIA19 and by DDDvet and DCDvet the
corresponding percentages were 29.8% and 20.0%.
HPCIA sales were dominated by sales of Macrolides
to dairy herds. The total mass of HPCIA was, for beef,
0.59 mg/kg of bovine animal (Den_all), and for dairy,
1.91 mg/kg. Colistin, another HPCIA, was not sold
to any of the contributing herds during the study
period. The total mass of parenteral HPCIA per PCU
(PCUD_std, Supporting information Tables S1 and S2)
for dairy herds was 0.56 mg/PCU (Table 4). The total
number of DCDvet HPCIA intramammary use antimi-
crobials in our study was 0.62 per dairy cow.
DISCUSSION
Principal findings
Farmers are being encouraged to reduce AMU at
national and global levels.5,20 Given difficulties in
obtaining consumption data, sales data act as a
proxy. Attempts have been made to estimate sales
data for veterinary antimicrobials at international,21
national22 and individual herd levels.10,12,23–25 Our
paper complements these and provides dairy and beef
herd-level data for Scotland.
We found that herd size and total sales were strongly
correlated, dairy herds were sold more antimicrobial
(AM) per PCU than beef, and dairy were sold consid-
erably more intramammary products than beef herds.
The DDDvet was, in general, about three to five times
higher than the DCDvet (Table 3), which concords
with definitions and previous results.10
With such a complex set of stages to process data,
there is a risk of unobserved processing errors. It was
therefore encouraging (although far from definitive) to
find that there was a strong correlation between herd
size and total sales, that dairy herds were sold more
AM per PCU than beef, and that dairy were sold much
more intramammary products than beef herds.
We also note the following similarities between
Figure 2 in our study and a similar one of English dairy
farms10 (although our Figure 2 expresses the estimates
of AMU per kg of all bovines to enable comparison
between dairy and beef estimates):
∙ Most of the antimicrobials (by mass per kg of
all bovines) sold to dairy herds were injectable/
parenteral.
∙ Of the injectable/parenteral and intramammary
antimicrobials, the greatest mass per kg of all
bovines was contributed by aminoglycosides and
beta lactams (excluding third-/fourth-generation
cephalosporins). Beta lactams were recorded as
being highly used in similar studies of dairy
farms.26,27
Measures of antimicrobial used (the
numerator)
Others have discussed the advantages and disadvan-
tages of different metrics of AMU.8 When comparing
populations to one another or to the overall mean or
median, the choice of metric can be very important
and lead to different conclusions, such as a change in
relative ranking.8
Some antimicrobials require less mass of active
ingredient per treatment: among the antimicrobials in
our data, the DDDvet (mg/kg) varied by more than one
order of magnitude between products (0.3–41 mg/kg).





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































T A B L E 4 Total usage of antimicrobials classed as HPCIA, as sold to dairy herds in this study based on RUMA targets. Numerator and the
respective denominator are selected to allow comparison with the RUMA baseline estimates and setting of targets in 2017 (RUMA 2017)







F I G U R E 1 (a) Total sales of active ingredient (mg) per kg of all bovine animals broken down by route of administration and herd type.
‘CT’ represents ‘cow therapy’. (b) Total DDDvet broken down by route of administration and herd type. In the case of parenteral, topical
and oral routes of administration the denominator is the total kg of all bovine animals. In the case of the intra-mammaries (both dry and
lactating cow therapy) the denominator is number of adult cows. “CT” represents “cow therapy”. (c) Total DCDvet broken down by route of
administration and herd type. In the case of parenteral, topical and oral routes of administration the denominator is the total kg of all bovine
animals. In the case of the intra-mammaries (both lactating cow therapy) the denominator is a number ‘of adult cows. ‘CT’ represents ‘cow
therapy’
between groups of animals, if the antimicrobials are
different between the animal groups, depending on
the metric used, means that no single comparison is
‘correct’. Such comparisons between groups where
the antimicrobials are very different should be treated
with care.
It appears that measurement of AMU is a fast-
moving discipline and still requires further standard-
isation and consistency over time. For example, it
is not clear that there is a single standard for the
weight of an adult dairy cow with values of 425, 500
and 600 kg being used.17,28–30 In addition to differ-
ences between authors, there are also changes over
time, including changes in antimicrobial classifica-
tion with HPCIAs for some including macrolides19,43
while another recent classification has relabelled
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F I G U R E 2 Breakdown of total weight of antimicrobials sold (mg a.i. per kg of bovine animal) by herd type, route of administration and
antimicrobial class. CT refers to ‘cow therapy’
their highest priority category as ‘Category B’ or
‘Restrict’.31,32
Choice of denominator (PCU or total mass
of bovine animal)
Several concerns regarding the calculation of the
denominator are exposed by our study, particularly
when applying definitions of denominators created for
national-level estimates to individual herds:
∙ For beef herds, in the absence of appropriate data
on the slaughter population, we were obliged to con-
sider proxies for this denominator as well as denom-
inators that might allow for reasonable comparison
with dairy herds.
∙ The standard masses per animal of each demo-
graphic type is considered inaccurate in many situ-
ations: consider, for example, the standard mass for
an adult cow (at the time of treatment) of 425 kg (see
the Supporting Information) compared to an esti-
mate of 650 kg for a high output dairy cow housed
year-round33 and alternative estimates of mass 500
and 600 kg cited previously.8 Any simplification of
‘herd size’ for the purposes of standardisation will
result in such inaccuracies, and we accept them in
return for the benefits of comparison provided by
standardisation.
∙ Demographic data at the individual herd-level can
be more variable over time than demographic data
at the national level. Therefore, data such ours,
based on a snap-shot of individual herd demo-
graphics, which may not be representative of an
entire year, may inappropriately exaggerate vari-
ation in our estimates of usage and recent work
recommends averaging of liveweight over time to
ameliorate this.32
Our results demonstrated high variation in esti-
mates of usage per PCU between herd-years and that
they are particularly sensitive to the value of the
denominator. Due to this sensitivity, we have con-
cerns about estimates that utilise denominators based
on snap-shots of herd demographics for comparing
small (e.g. herd-level) groups of animals that are dif-
ferent in demographic composition.34 Published esti-
mates of AMU per PCU (or other mass of animal)
tend to be based on PCU calculated either from
questionnaires,35–37 or existing databases.10,23,24,38
Details of exactly what the demographic data rep-
resent or how calculations are made are not always
explicitly stated.26,27,39,40 The data and methods used
for such estimations should be clearly described to
enable appropriate comparisons.
It is likely that these difficulties are less important
when estimation is done at a national level. RUMA
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stated that ‘the ESVAC methodology is required to
calculate antibiotic use at a national level. However,
the Beef Antimicrobial Use Working Group has iden-
tified that this method is not best suited for on-farm
benchmarking and that there is a need to establish a
separate standard protocol’.5 Such questions are being
considered by industry,41,42 and recent work recom-
mends standards that include proposed solutions to
the fact that animal numbers vary through the year
(‘important that the weight of antibiotic used (in mg)
is interpreted relative to the average live-weight of
animal population’).32
Estimates in context
The UK’s contribution to the international effort in
reducing AMR and AMU includes targets for AMU in
agriculture.5 The RUMA task force targets are a 10%
reduction or 10 mg/kg of animal (whichever is lower)
for beef and 21 mg/kg of animal for dairy – both by
2020. Whether the group of farms in our study satis-
fied these targets (in advance) depends on the chosen
assumptions in the calculation. Our estimates of AMU
in total for both beef and dairy and HPCIA injecta-
bles in dairy compare favourably to (2017) RUMA
2020 targets. HPCIA intra-mammaries were substan-
tially higher than the RUMA 2020 target, mainly due
to the sale of macrolides reflecting recent evidence
from elsewhere.43 It suggests that the RUMA targets
are achievable at least for injectables in these herds.
It is encouraging from a public health viewpoint to
note that, for this practice at least, a small proportion
of the antimicrobials sold were Highest Priority Criti-
cally Important (HPCI): we estimated 10.6% by mass
of antimicrobials sold were HPCI and 29.8% and 20.0%
by DDDvet and DCDvet, respectively. This usage was
predominantly in the dairy herds, and, within dairy
herds, it was primarily through the usage of macrolides
followed by cephalosporins. Therefore, any targeting
to reduce HPCIA usage in cattle might start with
macrolides and cephalosporins in dairy herds. This
already is being addressed through mastitis control
programmes promoted by Agriculture and Horticul-
ture Development Board (AHDB)44 and quality assur-
ance schemes required by dairy companies (e.g. Red
Tractor Quality Assurance45). Programmes to reduce
disease, such as the above,44 have a wider benefit
because they are highly effective ways of reducing
AMU in general – not just targeted antimicrobials.
Limitations
There are several limitations of our approach concern-
ing our use of antimicrobial sales data and the source
of these data:
∙ The data come from one veterinary practice, which
may not be typical of other Scottish practices.
∙ Data are based on sales rather than direct usage.
We cannot determine how much antimicrobial sold
went unused (whether discarded, used in other live-
stock or stored for use in subsequent years), or
whether antimicrobials were obtained from other
sources.
∙ These data describe antimicrobial sales for a par-
ticular time period (2011–2015). They likely do not
represent current (2020) sales. Nonetheless, these
data are likely to be useful for future compari-
son/benchmarking.
∙ Our estimates were based on the sales cost of the
item according to a 2016 price list. We assumed that
the prices of products did not change appreciably
during the period of interest, and that the relation-
ship between cost of a sale and the amount of prod-
uct sold in that sale was proportional.
∙ It is possible that some herds had other livestock
(in particular sheep) which may have received some
of antimicrobials contributing to our dataset and
therefore were assumed to have been given to cat-
tle. If this occurred then it would provide an over-
estimate of the AMU on that farm. We think it likely
this did occur, we cannot currently estimate the size
of this effect but assume that it is not large because
of the consumption of antimicrobials by sheep is
considered to be very low as indicated by compar-
ing sales of sheep only products with sales specific
to other species.46 Future studies will need to seek
to account for usage of products (licensed for more
than one species) by species other than the target
species (e.g. ‘Alamycin LA 300’) ideally by separat-
ing the usage for the different species or by exclud-
ing farms that have sheep and accepting a different
consequent bias.7
∙ We have included certain antimicrobials such as
those that can be used through the ‘Cascade’ for off-
licence use in footbaths (e.g. Tylan solution), which
may be used in such quantities that they can be
strong determinants of total usage (by mass) at the
herd level.8,10 To include them seems proper, but
they may disproportionately affect total usage in
specific herd-years.
Other limitations affect the herd-level demographic
data used in this study:
∙ Standardised definitions are not always consistently
referred to within the literature (e.g. standard weight
of an adult dairy cow or the definition of a DCDvet
for intramammary tubes in dry cows).
∙ The distinction between beef and dairy herds is
not always clear. Our definition of a dairy herd
meant that some dairy herds had some beef ani-
mals within them and vice versa. This concords with
the Scottish Dairy Cattle Association’s definition,11
but does not account for mixed herds, which is
likely to have affected the calculated PCU for some
herds.
∙ Herd demographics were represented by a single
snap-shot at a particular point in time each year.
The implications of this are discussed above. The
use of cattle movement data47 to more accurately
represent herd demographic dynamics may be more
suitable.
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∙ For beef herds, we made further assumptions
regarding the livestock which went to slaughter. This
limitation reflects the difficulties that arise when try-
ing to compare different sectors whose definition of
PCU rely on different data. As above, the use of cattle
movement data may ameliorate this difficulty.
Recommendations
Based on this study, we recommend that billing data
continue to be considered a valuable resource for esti-
mating AMU, and that attempts to standardise the
recording of billing data within, and between, prac-
tices be progressed.41
We recognise that the definitions of PCU were cre-
ated for national-level estimates and suggest that com-
parisons based on estimated denominators such as
PCU should only be made between groups of animals
that have similar demographic composition.34 A more
appropriate definition of PCU for use at the individual
herd level, and which allows for the existence of herds
that include both dairy products and beef animals, is
needed for herd-level comparison and benchmarking.
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